关注我们
Davunetide
添加购物车| 名称 | Davunetide |
|---|---|
| CAS No. | 211439-12-2 |
| 目录号 | ONP20129 |
| 规格 | mg/g/kg |
| 纯度 | ≥98% |
| 价格 | 更多在线询价 |
| 贮存 | -20°C |
| 分子量 | 824.934 |
| 序列结构 | H-Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH |
| 库存 | |
| 产品简述 | Davunetide has been used in trials studying the treatment of Progressive Nonfluent Aphasia, Progressive Supranuclear Palsy, Predicted Tauopathies, Including, Corticobasal Degeneration Syndrome, and Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17. Davunetide is the first drug to improve memory performance by impacting the mechanisms that lead to physical damage in the brain caused by neurofibrillary tangles, one of the two established pathological hallmarks that are common to amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD). |